Jeanne Oiticica
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jeanne Oiticica has a total of 213 co-authors. Here are the top co-authors by number of shared publications:
- Ricardo Ferreira Bento
Department of Otorhinolaryngology, University of São Paulo School of Medicine, São Paulo, Brazil
18 shared publications - Ana Carla Batissoco
Laboratório de Otorrinolaringologia/LIM 32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo São Paulo Brazil
15 shared publications - Regina Célia Mingroni-Netto
Universidade de São Paulo
15 shared publications - Karina Lezirovitz
Laboratório de Otorrinolaringologia/LIM 32, Hospital das Clínicas HCFMUSP, Faculdade de Medicina Universidade de São Paulo São Paulo São Paulo Brazil
13 shared publications - Roseli Saraiva Moreira Bittar
Department of Otolaryngology, University of São Paulo School of Medicine, Av. Dr. Enéas de Carvalho Aguiar, 255, São Paulo 05403-000, SP, Brazil
12 shared publications - Rodrigo Salazar-Silva
Centro de Pesquisas sobre o Genoma Humano e Células-Tronco, Departamento de Genética e Biologia Evolutiva, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
6 shared publications
Latest Publications
- Open Access
- 1 October 2026
- Published by Wiley in Cell Biology International
- Vol. 50 (10) , e70218
Proteomic Signatures of Noise‐Induced Hearing Loss in the Mouse Cochlea
Hearing loss affects over 1.5 billion people worldwide and has substantial social, educational, and economic consequences. Although genetic studies have identified numerous hearing‐loss‐associated genes, the molecular changes accompanying noise‐induced hearing loss (NIHL) remain incompletely understood. We characterized the adult mouse cochlear proteome following damaging noise exposure using nano‐LC–MS/MS and an integrative bioinformatics workflow. Comparative profiling of normal‐hearing and NIHL cochleae identified 1742 proteins and an 80‐protein NIHL‐associated signature comprising 49 quantitatively defined differentially abundant proteins and 31 condition‐specific proteins. These proteins were organized into five functional groups encompassing metabolic and mitochondrial function, protein synthesis and ribonucleoprotein complexes, structural and synaptic organization, cell polarity and cytoskeletal remodeling, and regulatory and stress‐responsive functions. Representative alterations included reduced HSPA9, a mitochondrial chaperone involved in protein homeostasis; changes in the RNA‐associated proteins PRMT1 and CIRBP; reduced HAPLN1, associated with extracellular matrix organization; and altered MAP2K2, a signaling protein related to cell polarity; and increased SYNJ2. Comparison with an independent cochlear proteomic data set identified 39 of the 80 proteins as dysregulated, with 22 showing concordant directional changes. Single‐cell transcriptomic mapping provided cellular context for 74 of the 80 protein‐associated genes, while human genetic and disease annotations supported the prioritization of selected proteins associated with hearing or ear phenotypes. Together, these findings define a proteomic landscape of the noise‐exposed cochlea and identify molecular candidates and cellular processes for further investigation of NIHL.
- 1 October 2026
- Published by Wiley in Cell Biology International
- Vol. 50 (10) , e70218
Open AccessProteomic Signatures of Noise‐Induced Hearing Loss in the Mouse Cochlea
Hearing loss affects over 1.5 billion people worldwide and has substantial social, educational, and economic consequences. Although genetic studies have identified numerous hearing‐loss‐associated genes, the molecular changes accompanying noise‐induced hearing loss (NIHL) remain incompletely understood. We characterized the adult mouse cochlear proteome following damaging noise exposure using nano‐LC–MS/MS and an integrative bioinformatics workflow. Comparative profiling of normal‐hearing and NIHL cochleae identified 1742 proteins and an 80‐protein NIHL‐associated signature comprising 49 quantitatively defined differentially abundant proteins and 31 condition‐specific proteins. These proteins were organized into five functional groups encompassing metabolic and mitochondrial function, protein synthesis and ribonucleoprotein complexes, structural and synaptic organization, cell polarity and cytoskeletal remodeling, and regulatory and stress‐responsive functions. Representative alterations included reduced HSPA9, a mitochondrial chaperone involved in protein homeostasis; changes in the RNA‐associated proteins PRMT1 and CIRBP; reduced HAPLN1, associated with extracellular matrix organization; and altered MAP2K2, a signaling protein related to cell polarity; and increased SYNJ2. Comparison with an independent cochlear proteomic data set identified 39 of the 80 proteins as dysregulated, with 22 showing concordant directional changes. Single‐cell transcriptomic mapping provided cellular context for 74 of the 80 protein‐associated genes, while human genetic and disease annotations supported the prioritization of selected proteins associated with hearing or ear phenotypes. Together, these findings define a proteomic landscape of the noise‐exposed cochlea and identify molecular candidates and cellular processes for further investigation of NIHL.
- Open Access
- 3 June 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (2) , 210-226
Genetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations
Hearing loss (HL) is the most prevalent sensory disorder globally and a major public health challenge in Brazil, affecting over 1.5 million individuals. While over 150 HL‐associated genes have been identified, the genetic architecture in underrepresented populations remains poorly defined, often limiting diagnostic yield and precision medicine. We assessed the diagnostic performance of a comprehensive 218‐gene HL panel in 99 Brazilian probands (78 non‐syndromic; 21 syndromic) who had previously tested negative for GJB2/GJB6 (DFNB1) and MT‐RNR1 (m.1555A>G) and did not have ear malformations. Targeted next‐generation sequencing was followed by variant interpretation according to ACMG/AMP guidelines, segregation analysis, and longitudinal phenotypic re‐evaluation. Integration of Brazil‐specific allele‐frequency data was used to refine variant classification. A molecular diagnosis or a candidate variant was identified in 61 probands, yielding an overall diagnostic yield of 43%–62%, depending on classification stringency. We identified 19 novel variants across 15 genes, with MYO7A and MYO15A as the most frequently implicated. Notably, 10.4% of patients initially diagnosed with non‐syndromic HL carried pathogenic or likely pathogenic variants in syndromic genes ( PEX6, BSND, USH1C , and WFS1 ), necessitating clinical reclassification. Segregation analysis and phenotypic reassessment further enabled the reclassification of three variants of uncertain significance (VUS). In syndromic cases, a molecular diagnosis was established in 41% of cases, including Usher, Waardenburg, Branchio‐oto‐renal, and Bartter syndromes. This first large‐scale clinical genetic evaluation of hearing loss in Brazil demonstrates that comprehensive gene panels incorporating population‐specific data significantly improve diagnostic accuracy. Our findings broaden the mutational landscape of HL‐associated genes, reinforce the value of integrated genetic approaches for underrepresented populations, and underscore their direct impact on patient care and clinical management.
- 3 June 2026
- Published by Wiley in Clinical Genetics
- Vol. 110 (2) , 210-226
Open AccessGenetic Landscape of Hearing Loss in Brazilian Patients Reveals Population‐Specific Variants and Clinical Correlations
Hearing loss (HL) is the most prevalent sensory disorder globally and a major public health challenge in Brazil, affecting over 1.5 million individuals. While over 150 HL‐associated genes have been identified, the genetic architecture in underrepresented populations remains poorly defined, often limiting diagnostic yield and precision medicine. We assessed the diagnostic performance of a comprehensive 218‐gene HL panel in 99 Brazilian probands (78 non‐syndromic; 21 syndromic) who had previously tested negative for GJB2/GJB6 (DFNB1) and MT‐RNR1 (m.1555A>G) and did not have ear malformations. Targeted next‐generation sequencing was followed by variant interpretation according to ACMG/AMP guidelines, segregation analysis, and longitudinal phenotypic re‐evaluation. Integration of Brazil‐specific allele‐frequency data was used to refine variant classification. A molecular diagnosis or a candidate variant was identified in 61 probands, yielding an overall diagnostic yield of 43%–62%, depending on classification stringency. We identified 19 novel variants across 15 genes, with MYO7A and MYO15A as the most frequently implicated. Notably, 10.4% of patients initially diagnosed with non‐syndromic HL carried pathogenic or likely pathogenic variants in syndromic genes ( PEX6, BSND, USH1C , and WFS1 ), necessitating clinical reclassification. Segregation analysis and phenotypic reassessment further enabled the reclassification of three variants of uncertain significance (VUS). In syndromic cases, a molecular diagnosis was established in 41% of cases, including Usher, Waardenburg, Branchio‐oto‐renal, and Bartter syndromes. This first large‐scale clinical genetic evaluation of hearing loss in Brazil demonstrates that comprehensive gene panels incorporating population‐specific data significantly improve diagnostic accuracy. Our findings broaden the mutational landscape of HL‐associated genes, reinforce the value of integrated genetic approaches for underrepresented populations, and underscore their direct impact on patient care and clinical management.
- Open Access
- 24 April 2026
- Published by Georg Thieme Verlag KG in International Archives of Otorhinolaryngology
- Vol. 30 (02) , 001-011
A Structural Variant in the 5' Regulatory Region of DIAPH3 Segregates with Postlingual Hearing Loss and Auditory Neuropathy in a Multigenerational Brazilian Family
Hearing loss is genetically diverse, as it is caused by alterations in many genes and diverse inheritance patterns. While most causative variants are found in coding regions, noncoding regulatory variants can alter gene expression and may not be detected by standard exome sequencing analysis. To identify the genetic cause of autosomal dominant postlingual hearing loss in a large Brazilian family with 39 affected individuals and to describe their clinical features. Comprehensive audiological and imaging evaluations were conducted. Whole-exome sequencing on four affected subjects, supplemented by structural-variant analysis, identified a candidate variant later confirmed by quantitative polymerase chain reaction (qPCR), PCR, and Sanger sequencing. Audiological testing of 61 relatives identified 31 individuals with progressive sensorineural hearing loss or auditory neuropathy linked to autosomal dominant inheritance. Genetic analysis revealed a DIAPH3 5'UTR deletion-insertion (c.-216_-46delinsAAGAA) that perfectly cosegregated with this specific phenotype. Notably, eight other affected relatives exhibited different clinical forms of hearing loss but did not carry the DIAPH3 variant, suggesting separate underlying causes for their symptoms. Identification of this regulatory structural variant supports the role of DIAPH3 in the etiological diagnosis of postlingual hearing loss and auditory neuropathy, with direct implications for genetic counseling and clinical management.
- 24 April 2026
- Published by Georg Thieme Verlag KG in International Archives of Otorhinolaryngology
- Vol. 30 (02) , 001-011
Open AccessA Structural Variant in the 5' Regulatory Region of DIAPH3 Segregates with Postlingual Hearing Loss and Auditory Neuropathy in a Multigenerational Brazilian Family
Hearing loss is genetically diverse, as it is caused by alterations in many genes and diverse inheritance patterns. While most causative variants are found in coding regions, noncoding regulatory variants can alter gene expression and may not be detected by standard exome sequencing analysis. To identify the genetic cause of autosomal dominant postlingual hearing loss in a large Brazilian family with 39 affected individuals and to describe their clinical features. Comprehensive audiological and imaging evaluations were conducted. Whole-exome sequencing on four affected subjects, supplemented by structural-variant analysis, identified a candidate variant later confirmed by quantitative polymerase chain reaction (qPCR), PCR, and Sanger sequencing. Audiological testing of 61 relatives identified 31 individuals with progressive sensorineural hearing loss or auditory neuropathy linked to autosomal dominant inheritance. Genetic analysis revealed a DIAPH3 5'UTR deletion-insertion (c.-216_-46delinsAAGAA) that perfectly cosegregated with this specific phenotype. Notably, eight other affected relatives exhibited different clinical forms of hearing loss but did not carry the DIAPH3 variant, suggesting separate underlying causes for their symptoms. Identification of this regulatory structural variant supports the role of DIAPH3 in the etiological diagnosis of postlingual hearing loss and auditory neuropathy, with direct implications for genetic counseling and clinical management.
- Open Access
- 9 October 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 90 (1) , 101340
White noise effect on listening effort among patients with chronic tinnitus and normal hearing thresholds
- 9 October 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 90 (1) , 101340
Open AccessWhite noise effect on listening effort among patients with chronic tinnitus and normal hearing thresholds
- Open Access
- 5 July 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (Suppl 3) , S109-S116
Translation and validation of the Tinnitus Primary Function Questionnaire into Brazilian Portuguese
- 5 July 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (Suppl 3) , S109-S116
Open AccessTranslation and validation of the Tinnitus Primary Function Questionnaire into Brazilian Portuguese
- Open Access
- 20 May 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (Suppl 3) , S164-S170
Hearing aid effectiveness on patients with chronic tinnitus and associated hearing loss
- 20 May 2022
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 88 (Suppl 3) , S164-S170
Open AccessHearing aid effectiveness on patients with chronic tinnitus and associated hearing loss
- 1 January 2022
- Published by Elsevier in Brain Research
- Vol. 1775, 147728
Evaluating the efficacy of hearing aids for tinnitus therapy – A Positron emission tomography study
- 1 January 2022
- Published by Elsevier in Brain Research
- Vol. 1775, 147728
Evaluating the efficacy of hearing aids for tinnitus therapy – A Positron emission tomography study
- Open Access
- 11 November 2021
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 31 (1) , 156
Corrigendum to: NCOA3 identified as a new candidate to explain autosomal dominant progressive hearing loss
In the originally published version of this manuscript, the Wellcome Trust funding was omitted. The funding section should mention Wellcome Trust grant number 108907/Z/15/Z. This error has been corrected online.
- 11 November 2021
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 31 (1) , 156
Open AccessCorrigendum to: NCOA3 identified as a new candidate to explain autosomal dominant progressive hearing loss
In the originally published version of this manuscript, the Wellcome Trust funding was omitted. The funding section should mention Wellcome Trust grant number 108907/Z/15/Z. This error has been corrected online.
- 1 October 2021
- Published by Springer Nature in Human Genetics
- Vol. 141 (3-4) , 519-538
Molecular and genetic characterization of a large Brazilian cohort presenting hearing loss
Hearing loss is one of the most common sensory defects, affecting 5.5% of the worldwide population and significantly impacting health and social life. It is mainly attributed to genetic causes, but their relative contribution reflects the geographical region’s socio-economic development. Extreme genetic heterogeneity with hundreds of deafness genes involved poses challenges for molecular diagnosis. Here we report the investigation of 542 hearing-impaired subjects from all Brazilian regions to search for genetic causes. Biallelic GJB2/GJB6 causative variants were identified in 12.9% (the lowest frequency was found in the Northern region, 7.7%), 0.4% carried GJB2 dominant variants, and 0.6% had the m.1555A > G variant (one aminoglycoside-related). In addition, other genetic screenings, employed in selected probands according to clinical presentation and presumptive inheritance patterns, identified causative variants in 2.4%. Ear malformations and auditory neuropathy were diagnosed in 10.8% and 3.5% of probands, respectively. In 3.8% of prelingual/perilingual cases, Waardenburg syndrome was clinically diagnosed, and in 71.4%, these diagnoses were confirmed with pathogenic variants revealed; seven out of them were novel, including one CNV. All these genetic screening strategies revealed causative variants in 16.2% of the cases. Based on causative variants in the molecular diagnosis and genealogy analyses, a probable genetic etiology was found in ~ 50% of the cases. The present study highlights the relevance of GJB2/GJB6 as a cause of hearing loss in all Brazilian regions and the importance of screening unselected samples for estimating frequencies. Moreover, when a comprehensive screening is not available, molecular diagnosis can be enhanced by selecting probands for specific screenings.
- 1 October 2021
- Published by Springer Nature in Human Genetics
- Vol. 141 (3-4) , 519-538
Molecular and genetic characterization of a large Brazilian cohort presenting hearing loss
Hearing loss is one of the most common sensory defects, affecting 5.5% of the worldwide population and significantly impacting health and social life. It is mainly attributed to genetic causes, but their relative contribution reflects the geographical region’s socio-economic development. Extreme genetic heterogeneity with hundreds of deafness genes involved poses challenges for molecular diagnosis. Here we report the investigation of 542 hearing-impaired subjects from all Brazilian regions to search for genetic causes. Biallelic GJB2/GJB6 causative variants were identified in 12.9% (the lowest frequency was found in the Northern region, 7.7%), 0.4% carried GJB2 dominant variants, and 0.6% had the m.1555A > G variant (one aminoglycoside-related). In addition, other genetic screenings, employed in selected probands according to clinical presentation and presumptive inheritance patterns, identified causative variants in 2.4%. Ear malformations and auditory neuropathy were diagnosed in 10.8% and 3.5% of probands, respectively. In 3.8% of prelingual/perilingual cases, Waardenburg syndrome was clinically diagnosed, and in 71.4%, these diagnoses were confirmed with pathogenic variants revealed; seven out of them were novel, including one CNV. All these genetic screening strategies revealed causative variants in 16.2% of the cases. Based on causative variants in the molecular diagnosis and genealogy analyses, a probable genetic etiology was found in ~ 50% of the cases. The present study highlights the relevance of GJB2/GJB6 as a cause of hearing loss in all Brazilian regions and the importance of screening unselected samples for estimating frequencies. Moreover, when a comprehensive screening is not available, molecular diagnosis can be enhanced by selecting probands for specific screenings.